Status message

Active context: kki_bg_colors_yellow

A Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety and Tolerability of Desvenlafaxine Succinate Sustained-Release (Dvs Sr) in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder

Principal Investigator:
Robert
Findling

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety and Tolerability of Desvenlafaxine Succinate Sustained-Release (Dvs Sr) in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder

To evaluate the efficacy of DVS SR compared with placebo in the treatment of children and adolescents with Major Depressive Disorder (MDD) as measured by the Children’s Depression Rating Scale – Revised (CDRS-R) total score.

Publications

Read inspiring stories, news and updates about the Institute's patient care, research, special education, professional training, and community programs.